Research Spotlight: A Clinical Trial for Epileptic Encephalopathy with Continuous Spike-and-Wave during Sleep

Neurocrine Biosciences is looking for children 4 to 12 years old with a clinical diagnosis of EECSWS to take part in the Steamboat Study, a 21-week clinical research study. The primary purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication for EECSWS. To learn more, visit SteamboatEpilepsy.com.

Comments